$GENI

Russell Thomas sold $326K of GENI

Russell Thomas (Chief Legal Officer) sold 50,000 shares of Genius Sports Ltd (GENI) at $6.51 ($0.33M total) on 2026-09-17.

Original reporting
SEC EDGAR · Russell Thomas
Published Sep 18, 2026, 8:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 18, 2026, 8:45 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$GENI
Bearish
medium confidence
Mentioned
$GENI
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$GENIBearishLow
01

Why it matters

The disclosed sale is the first public report of this transaction, offering new data for traders.

02

Market read

Small insider sale may cause slight short-term price pressure but unlikely to drive major market moves.

03

What to watch

Sale represents only ~10% of insider's remaining holdings, reducing materiality.

Relevance 4/10Novelty 4/10Timing: post-market 2026-09-18

Background

Form 4 filing discloses insider transactions required by SEC; provides transparency on officer holdings.

Company-level read

Ticker impact

$GENIBearishMedium confidence
Context

Chief Legal Officer Russell Thomas sold 50,000 shares for $325,565 on 2026-09-17, disclosed via Form 4.

Expected impact

Potential modest dip in next trading session.

Evidence & confidence

Sale size is modest relative to holdings but involves a senior officer; market may view as a slight negative cue.

Market effects

Minimal impact on sports data sector.

Limited to US-listed sports data stocks.

Low

Counterpoint

Insider sale may be routine portfolio rebalancing, not a negative signal.

Key entities

  • Russell Thomas

    Chief Legal Officer of Genius Sports Ltd.

  • Genius Sports Ltd

    Provider of sports data and technology solutions.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$GENIMed

Genius, CF, 3M, Nike, Synopsys Trending With Analysts

Analysts cover five stocks: Genius Sports (GENI) with a $8 target, CF Industries (CF) with a $162 target, 3M (MMM) upgraded to Hold with a $171 target, Nike (NKE) downgraded to Sell with a $30 target, and Synopsys (SNPS) upgraded to Buy with a $700 target. Analysts cite growth, valuation, and market conditions as key factors.

$GENIMedAI 8/10

Why Genius Sports Popped by Almost 10% This Week

Genius Sports (NYSE: GEN) rose nearly 10% over the week after its Q2 results beat revenue expectations and the company raised 2026 guidance. Revenue was $196M versus $185M guidance and just under consensus. Net loss widened to about $77M ($0.28/share). Full-year revenue guidance increased to about $1.03B and adjusted EBITDA to $285M-$295M.

$GENIMed

Genius Sports Builds Prediction Market Foundation with Kalshi and Polymarket Official Data Agreements

Genius Sports said it signed official sports data agreements with Kalshi and Polymarket to support prediction market contract settlement, plus information sharing and integrity services with market-type restrictions. CEO Mark Locke discussed the deals on a Q2 earnings call. Genius reported Q2 group revenue of $195.5M (+65% YoY) and raised full-year guidance to $1.02B revenue and $290M adjusted EBITDA.

$GENIMed

Genius: Sportsbooks and prediction markets in acquisition battle

Genius Sports CEO Mark Locke said prediction markets are validating its May 1 acquisition of Legend, citing faster-than-expected synergies in customer acquisition, official data and partnerships. He referenced deals with Kalshi and Polymarket and said prediction-market revenue should structurally rise. Genius raised 2026 guidance to revenue $1.01bn-$1.03bn and adjusted EBITDA $285m-$295m.